Business

CVS makes more than $66 billion bid for Aetna

CVS makes more than $66 billion bid for Aetna

The company has a market value of about $75 billion, while Aetna was valued at about $53 billion before surging on the Journal's report. The sources did not specify how much of CVS' bid is cash versus stock, but given CVS's and Aetna's market capitalizations of $77 billion and $54 billion, respectively, a substantial stock component is likely in any deal.


Bound flights face new screenings

Bound flights face new screenings

Passengers on Air France flights to the U.S.at Orly Airport said they faced additional questioning at Check In about their luggage, a move which the airline said was new, despite being common place on other airlines. "These measures, both seen and unseen, include enhanced screening of passengers and electronic devices as well as heightened security standards for aircraft and airports".



The Quadrant Capital Group LLC Increases Position in Boston Scientific Corp. (BSX)

Among the recent developments, worth mentioning is the company's acquisition of Symetis, in a bid to fortify its European structural heart business. The company's market capitalization is $32.35 billion. If you are accessing this story on another site, it was stolen and republished in violation of USA and worldwide trademark & copyright law. The correct version of this report can be read at ...


Jon Walters could still play against Denmark

Jon Walters could still play against Denmark

Ireland are away for the first leg in Copenhagen on Saturday, November 11 before returning to Dublin for the return match at the Aviva Stadium on Tuesday, November 14 with both games live on Sky Sports . Otherwise, O'Neill's 34-man squad is along expected lines. Another regular starter that could be making his return to the first team is James McCarthy.


The Anheuser Busch Inbev SA (BUD) Rating Reiterated by RBC Capital Markets

The Anheuser Busch Inbev SA (BUD) Rating Reiterated by RBC Capital Markets

It increased, as 30 investors sold ED shares while 223 reduced holdings. Community Healthcare Trust Inc (NYSE:CHCT) has risen 34.78% since October 25, 2016 and is uptrending. The firm has "Buy" rating given on Monday, October 3 by Liberum Capital. If we checked the overall image of stock during recent quarter then we found that stock performance is trading down -1.04%.



The Celgene Corp. (CELG) Stock Rating Reaffirmed by Jefferies Group

Thursday's results follow a major pipeline setback for Celgene on a med it previously picked up for $710 million. William Blair upgraded the stock to "Outperform" rating in Monday, April 3 report. Now it expects it will range from $7.25 to $7.35. COPYRIGHT VIOLATION NOTICE: This piece of content was first reported by Week Herald and is owned by of Week Herald.